ScinoPharm Taiwan, Ltd. announced the appointment of Jang-Yang Chang and Chyun-Yu Yang as Member of Compensation Committee. resume of the new position holder: Jang-Yang Chang¡, President of Taipei Cancer Center Distinguished Investigator and Director of Institute of Biotechnology and Pharmaceutical Research, NHRI and Chyun-Yu Yang, Honoring Superintendent and Professor of Department of Orthopedics, Kuo General Hospital Superintendent, National Cheng Kung University Hospital. Changes effective from May 29, 2023.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
